{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T02:47:33Z","timestamp":1778294853211,"version":"3.51.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2001,7,1]],"date-time":"2001-07-01T00:00:00Z","timestamp":993945600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2001,7,1]],"date-time":"2001-07-01T00:00:00Z","timestamp":993945600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr. Treat. Options in Oncol."],"published-print":{"date-parts":[[2001,7]]},"DOI":"10.1007\/s11864-001-0024-6","type":"journal-article","created":{"date-parts":[[2007,7,4]],"date-time":"2007-07-04T20:32:53Z","timestamp":1183581173000},"page":"309-318","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Primary central nervous system lymphomas"],"prefix":"10.1007","volume":"2","author":[{"given":"Lisa M.","family":"DeAngelis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"24_CR1","first-page":"1","volume":"6","author":"LM DeAngelis","year":"1992","unstructured":"DeAngelis LM, Yahalom J: Primary central nervous system lymphoma. In Principles and Practice of Oncology Updates. Edited by DeVita VT Jr, Hellman S, Rosenberg SA. Philadelphia: JB Lippincott; 1992:6:1\u201312.","journal-title":"Principles and Practice of Oncology Updates"},{"key":"24_CR2","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1212\/WNL.46.4.985","volume":"46","author":"MJ Glantz","year":"1996","unstructured":"Glantz MJ, Cole BF, Friedberg MH, et al.: A randomized, blinded, placebo-controlled trial of divalproex sodium prophylaxis in adults with newly diagnosed brain tumors. Neurology 1996, 46:985\u2013991.","journal-title":"Neurology"},{"key":"24_CR3","first-page":"A263","volume":"45","author":"S Weaver","year":"1995","unstructured":"Weaver S, Forsyth P, Fulton D, et al.: A prospective randomized study of prophylactic anticonvulsants (AC) in patients with primary brain tumors (PBT) or metastatic brain tumors (MBT) and without prior seizures (Sz): a preliminary analysis of 67 patients [abstract]. Neurology 1995, 45:A263.","journal-title":"Neurology"},{"key":"24_CR4","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1023\/A:1008376412784","volume":"11","author":"AJM Ferreri","year":"2000","unstructured":"Ferreri AJM, Reni M, Villa E: Therapeutic management of primary central nervous system lymphoma: lessons from prospective trials. Ann Oncol 2000, 11:927\u2013937. An excellent overview of current management and treatment.","journal-title":"Ann Oncol"},{"key":"24_CR5","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1023\/A:1008201717089","volume":"8","author":"M Reni","year":"1997","unstructured":"Reni M, Ferreri AJM, Garancini MP, et al.: Therapeutic management of primary central nervous system lymphoma in immunocompetent patients: results of a critical review of the literature. Ann Oncol 1997, 8:227\u2013234.","journal-title":"Ann Oncol"},{"key":"24_CR6","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1200\/JCO.1998.16.3.859","volume":"16","author":"LA Abrey","year":"1998","unstructured":"Abrey LA, DeAngelis LM, Yahalom J: Long-term survival in primary CNS lymphoma. J Clin Oncol 1998, 16:859\u2013863. Prolonged survival is seen with high-dose methotrexate and cranial radiotherapy, but significant neurotoxicity can be seen with prolonged follow-up.","journal-title":"J Clin Oncol"},{"key":"24_CR7","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1200\/JCO.2000.18.17.3144","volume":"18","author":"LE Abrey","year":"2000","unstructured":"Abrey LE, Yahalom J, DeAngelis LM: Treatment for primary central nervous system lymphoma (PCNSL): the next step. J Clin Oncol 2000, 18:3144\u20133150. Chemotherapy alone is equally efficacious to chemotherapy plus radiotherapy in older patients and less toxic.","journal-title":"J Clin Oncol"},{"key":"24_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1097\/00006123-200001000-00010","volume":"46","author":"LD McAllister","year":"2000","unstructured":"McAllister LD, Doolittle ND, Guastadisegni PE, et al.: Cognitive outcomes and long-term follow-up results after enhanced chemotherapy delivery for primary central nervous system lymphoma. Neurosurgery 2000, 46:51\u201360.","journal-title":"Neurosurgery"},{"key":"24_CR9","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/0360-3016(95)00207-F","volume":"33","author":"BP O\u2019Neill","year":"1995","unstructured":"O\u2019Neill BP, O\u2019Fallon JR, Earle JD, et al.: Primary central nervous system non-Hodgkin\u2019s lymphoma: survival advantages with combined initial therapy? Int J Radiat Oncology Biol Phys 1995, 33:663\u2013673.","journal-title":"Int J Radiat Oncology Biol Phys"},{"key":"24_CR10","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1002\/1097-0142(20000915)89:6<1359::AID-CNCR21>3.0.CO;2-9","volume":"89","author":"GM Mead","year":"2000","unstructured":"Mead GM, Bleehen NM, Gregor A, et al.: A medical research council randomized trial in patients with primary cerebral non-Hodgkin lymphoma. Cerebral radiotherapy with and without cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy. Cancer 2000, 89:1359\u20131370. This study finds that CHOP is ineffective for PCNSL.","journal-title":"Cancer"},{"key":"24_CR11","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1212\/WNL.46.2.435","volume":"46","author":"RJ Freilich","year":"1996","unstructured":"Freilich RJ, Delattre J-Y, Monjour A, et al.: Chemotherapy without radiation therapy as initial treatment for primary CNS lymphoma in older patients. Neurology 1996, 46:435\u2013439.","journal-title":"Neurology"},{"key":"24_CR12","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1200\/JCO.1998.16.9.3000","volume":"16","author":"V Sandor","year":"1998","unstructured":"Sandor V, Stark-Vancs V, Pearson D, et al.: Phase II trial of chemotherapy alone for primary CNS and intraocular lymphoma. J Clin Oncol 1998, 16:3000\u20133006.","journal-title":"J Clin Oncol"},{"key":"24_CR13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0360-3016(92)90538-S","volume":"23","author":"DF Nelson","year":"1992","unstructured":"Nelson DF, Martz KL, Bonner H, et al.: Non-Hodgkin\u2019s lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trail by the radiation therapy oncology group (RTOG): RTOG 8315. Int J Radiat Oncol Biol Phys 1992, 23:9\u201317.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"24_CR14","first-page":"361","volume":"111","author":"X Yu","year":"1998","unstructured":"Yu X, Liu Z, Tian Z, et al.: CT-guided stereotactic biopsy of deep brain lesions: report of 310 cases. Chin Med J (Engl) 1998, 111:361\u2013363.","journal-title":"Chin Med J (Engl)"},{"key":"24_CR15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3171\/jns.1998.89.1.0031","volume":"89","author":"AV Kulkarni","year":"1998","unstructured":"Kulkarni AV, Guha A, Lozano A, et al.: Incidence of silent hemorrhage and delayed deterioration after stereotactic brain biopsy. J Neurosurg 1998, 89:31\u201335.","journal-title":"J Neurosurg"},{"key":"24_CR16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/00006123-200007000-00011","volume":"47","author":"DI Sandberg","year":"2000","unstructured":"Sandberg DI, Bilsky MH, Souweidane MM, et al.: Ommaya reservoirs for the treatment of leptomeningeal metastases. Neurosurgery 2000, 47:49\u201355.","journal-title":"Neurosurgery"},{"key":"24_CR17","first-page":"166a","volume":"19","author":"JJ Raizer","year":"2000","unstructured":"Raizer JJ, DeAngelis LM, Zelentz AD, et al.: Activity of Rituximab in primary central nervous system lymphoma PCNSL. Proc ASCO 2000, 19:166a.","journal-title":"Proc ASCO"},{"key":"24_CR18","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1093\/jnci\/92.7.575","volume":"92","author":"M Reni","year":"2000","unstructured":"Reni M, Ferreri AJM, Landoni C, Villa E: Salvage therapy with temozolomide in an immunocompetent patient with primary brain lymphoma. J Natl Cancer Inst 2000, 92:575\u2013576.","journal-title":"J Natl Cancer Inst"}],"container-title":["Current Treatment Options in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-001-0024-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11864-001-0024-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-001-0024-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-001-0024-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T10:36:26Z","timestamp":1659090986000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11864-001-0024-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,7]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,7]]}},"alternative-id":["24"],"URL":"https:\/\/doi.org\/10.1007\/s11864-001-0024-6","relation":{},"ISSN":["1527-2729","1534-6277"],"issn-type":[{"value":"1527-2729","type":"print"},{"value":"1534-6277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,7]]},"assertion":[{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}